borderline significantP = 0.0556
Results suggested that patients in the NADM8 high group tend to be more sensitive to the treatment of PI3K inhibitor GDC-0941 as compared with the NADM8 low group, although it is borderline significant (P = 0.0556) due to the limited sample size ( Figure 6K ).